Biosimilars USA 2018

14th - 15th November 2018, New Jersey, USA

This fifth annual event will gather a global audience of biosimilar experts and industry-thought leaders to discuss biosimilar manufacturing and commercialization considerations specific to the U.S.

Fresh from the press: On March 7th, 2018, the U.S.-FDA’s Commissioner, Scott Gottlieb, MD, announced that Biosimilar medicines are now a top priority for the FDA. Join us this November to learn how to take advantage of the FDA’s focus on biosimilars, accelerate your biosimilar pipeline and achieve FDA approval.

Hear from a selection of carefully handpicked keynote addresses and case studies presented to you by top manufacturing and leading distributors of market approved biosimilars, as they offer a unique insight into the areas of manufacturing, commercialization, device design, uptake, switching, interchangeability, and regulations.

This event is CPD accredited.

#SMiBioSimUSA

 

PLUS TWO INTERACTIVE HALF-DAY PRE-CONFERENCE WORKSHOPS

Tuesday 25th September 2018, Copthorne Tara Hotel, Central London, UK

 

08.30 - 12.30

Workshop A: Decoding how Stakeholders may Drive Biosimilar Adoption

Workshop Leaders: Tucker Herbert, Manager, ZS Associates

Christina Corridon, Associate Principal, ZS Associates

 

13.30 - 17.00

Workshop B: Dealing with Life Sciences Patents at the PTAB

Workshop Leaders: Ha Kung Wong, Partner, New York, Fitzpatrick, Cella, Harpper & Scinto

John Kirkland, Director, Intellectual Property, Alkermes, Inc.

 

More details at: http://www.smi-online.co.uk/pharmaceuticals/northamerica/biosimilars-north-america?utm_medium=www.biosimilars-usa.com&utm_source=P-268&utm_campaign=farmavitaWB 

Featured Events

 
 
PPFe2 300x300 copy
  
Biosimilars Biobetters
 
Cell Gene Therapy
 
MEDCOMM18B 300x300px
 
Pharma Congress2018
 
MEDAFF18B 300x300px
 
European Antibody Congress 2018
 
World Immunotherapy Congress 2018
 
World Biosimilar Congress 2018
 
Clinical Trials Congress 2018